600161 天坛生物
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)7.21111.92310.45812.09215.110
总资产报酬率 ROA (%)4.9528.1867.1897.9509.224
投入资产回报率 ROIC (%)6.82411.1659.61310.60211.785

边际利润分析
销售毛利率 (%)55.67150.76249.07647.52949.394
营业利润率 (%)41.93634.84233.60730.27432.056
息税前利润/营业总收入 (%)41.06033.76332.10928.61931.187
净利润/营业总收入 (%)34.68229.13828.27025.99227.371

收益指标分析
经营活动净收益/利润总额(%)97.51197.33694.96999.83297.701
价值变动净收益/利润总额(%)1.9362.0691.9720.9670.104
营业外收支净额/利润总额(%)-0.100-0.356-0.410-0.3130.030

偿债能力分析
流动比率 (X)5.2235.9156.2829.3214.957
速动比率 (X)3.2313.6924.2676.6722.645
资产负债率 (%)11.43810.10512.17111.32220.025
带息债务/全部投入资本 (%)4.1443.6615.9676.975--
股东权益/带息债务 (%)2,278.4632,590.5861,547.2921,311.709490.162
股东权益/负债合计 (%)595.726685.127558.916614.298299.183
利息保障倍数 (X)-49.245-35.317-23.595-18.346-35.459

营运能力分析
应收账款周转天数 (天)1.2331.7771.8200.9690.000
存货周转天数 (天)427.494365.297371.289360.0570.000